Serena Hung, M.D., Senior Medical Director, Neurology Franchise at Wave Life Sciences, is the clinical lead of the Neurology (CNS) programs at Wave which include Huntington’s disease, amyotrophic lateral sclerosis, frontotemporal degeneration as well as spinocerebellar ataxia. She is a neurologist with subspecialty training in Movement Disorders, completed her fellowship training at the University of Toronto. Prior to joining industry, she cared for patients with movement disorders such as Huntington’s disease and Parkinson’s disease at her academic practice and was involved in clinical research at the Medical College of Wisconsin as Associate Professor of Neurology. She was a member of the Huntington Study Group and Parkinson Study Group. Prior to Wave, she worked at Biogen for 6 years where she worked on the clinical development of products in multiple sclerosis, Parkinson’s disease and other movement disorders.
3:00 PM–4:00 PM Jun 6, 2018 (US - Eastern)